Fisman, Enrique Z.
Tel Aviv University
6 papers on CoChatORCID 0000-0001-7055-4488
Most cited papers
- Verified
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
Tenenbaum, A., Motro, M., & Fisman, E. Z. (2005) · Cardiovascular Diabetology
Peroxisome Proliferator-Activated ReceptorsParaoxonase enzyme and polymorphisms
Cited by 246
- Verified
Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two–Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry
Klempfner, R., Erez, A., Sagit, B.-Z., Goldenberg, I., Fisman, E., Kopel, E., Shlomo, N., Israel, A., & Tenenbaum, A. (2016) · Circulation: Cardiovascular Quality and Outcomes
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 180
- Verified
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
Fisman, E. Z., & Tenenbaum, A. (2021) · Cardiovascular Diabetology
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 124
- Verified
Functional class in patients with heart failure is associated with the development of diabetes
Tenenbaum, A., Motro, M., Fisman, E. Z., Leor, J., Freimark, D., Boyko, V., Mandelzweig, L., Adler, Y., Sherer, Y., & Behar, S. (2003) · The American Journal of Medicine
Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management
Cited by 99
- Verified
Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial
for the BIP Study Group, Arbel, Y., Klempfner, R., Erez, A., Goldenberg, I., Benzekry, S., Shlomo, N., Fisman, E. Z., & Tenenbaum, A. (2016) · Cardiovascular Diabetology
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 40
- Verified
Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation
Ram, E., Lavee, J., Tenenbaum, A., Klempfner, R., Fisman, E. Z., Maor, E., Ovdat, T., Amunts, S., Sternik, L., & Peled, Y. (2019) · Cardiovascular Diabetology
Transplantation: Methods and OutcomesCardiac and Coronary Surgery Techniques
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free